Ribeiro, Renata Pietsch <br/><br/>
Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.  [electronic resource] 

 -  Neurochemical research  Mar 2013 
 - 660-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-6903 
<br/><br/><label>Standard No.: </label>10.1007/s11064-012-0965-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Catalase--metabolism<br/>Corpus Striatum--drug effects<br/>Dopaminergic Neurons--drug effects<br/>Lipid Peroxidation--drug effects<br/>Male<br/>Mice<br/>Motor Activity--drug effects<br/>Neuroprotective Agents--therapeutic use<br/>Oxidative Stress--drug effects<br/>Oxidopamine<br/>Parkinson Disease--drug therapy<br/>Probucol--therapeutic use<br/>Tyrosine 3-Monooxygenase--metabolism